T1	Outcomes 324 332	efficacy
T2	Outcomes 337 343	safety
T3	Outcomes 957 989	progression-free survival (PFS).
T4	Outcomes 1038 1048	Median PFS
T5	Outcomes 1171 1194	median overall survival
T6	Outcomes 1290 1313	objective response rate
T7	Outcomes 1357 1376	â‰¥3 adverse events
T8	Outcomes 1391 1411	included neutropenia
T9	Outcomes 1426 1438	and diarrhea
T10	Outcomes 1538 1557	toward improved PFS
T11	Outcomes 1577 1600	had acceptable toxicity
